Clinical Trial Update: Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening

View source ↗

Summary

This update reports a completed clinical trial evaluating once-daily evening dosing of valproate sustained-release minitablets (Orfiril Long) for epilepsy, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Orfiril Long (valproate)

Snippet

Sponsor: Desitin Arzneimittel GmbH | Conditions: Epilepsy | Status: COMPLETED | Results posted: 2009-03-27